Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Appointed director
Aquestive Therapeutics, Inc. (AQST) Create: Alert

All | News | Filings
Date FiledTypeDescription
08/09/2023 4 BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 75,000 rights @ $0
08/09/2023 4 Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 223,500 rights @ $0
08/09/2023 4 Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 75,000 rights @ $0
08/09/2023 4 Boyd Peter E. (See Remark) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 50,000 rights @ $0
08/09/2023 4 Kraus Carl N (Chief Medical Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 150,000 shares @ $0
08/09/2023 4 Wargacki Stephen (SVP, Research & Development) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 67,500 rights @ $0
08/09/2023 4 TOTH A ERNEST JR (SVP, CFO) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 70,000 rights @ $0
08/09/2023 4 Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 50,000 rights @ $0
08/09/2023 4 Jung Cassie (SVP, Operations) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 55,000 rights @ $0
06/30/2023 3 Kraus Carl N (CHIEF MEDICAL OFFICER) has filed a Form 3 on Aquestive Therapeutics, Inc.
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/05/2023 4 BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 75,000 rights @ $0
05/05/2023 4 Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 223,500 rights @ $0
05/05/2023 4 Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 75,000 rights @ $0
05/05/2023 4 Jung Cassie (SVP, Operations) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 55,000 rights @ $0
05/05/2023 4 Boyd Peter E. (See Remark) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 50,000 rights @ $0
03/09/2023 4 Boyd Peter E. (See Remark) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 100,000 shares @ $0
03/09/2023 4 Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 150,000 shares @ $0
03/09/2023 4 Jung Cassie (SVP, Operations) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 110,000 shares @ $0
03/09/2023 4 Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 100,000 shares @ $0
03/09/2023 4 Barber Daniel (President and CEO) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 447,000 shares @ $0
03/09/2023 4 BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 150,000 shares @ $0
03/09/2023 4 Wargacki Stephen (SVP, Research & Development) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 135,000 shares @ $0
03/09/2023 4 TOTH A ERNEST JR (SVP, CFO) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 140,000 shares @ $0
01/11/2023 3 Jung Cassie (SVP, Operations) has filed a Form 3 on Aquestive Therapeutics, Inc.
01/11/2023 3 Wargacki Stephen (SVP, Research & Development) has filed a Form 3 on Aquestive Therapeutics, Inc.
11/08/2022 4 Boyd Peter E. (SVP-Bus. Process & Info. Tech.) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 25,000 options to buy @ $0.875, valued at $21.9k
11/08/2022 4 BRAENDER LORI J (SVP, General Counsel) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $0.875, valued at $35k
11/08/2022 4 Marshall Ken W. (SVP, Chief Commercial Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $0.875, valued at $35k
11/08/2022 4 Schobel Alexander Mark (Chief Innovation/Tech Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $0.875, valued at $35k
11/08/2022 4 TOTH A ERNEST JR (SVP, CFO) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 40,000 options to buy @ $0.875, valued at $35k
09/08/2022 4 Truitt Kenneth (Chief Medical Officer) has filed a Form 4 on Aquestive Therapeutics, Inc.
Txns: Granted 100,000 options to buy @ $1.25, valued at $125k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy